Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY – Get Free Report)’s stock price rose 1.2% during mid-day trading on Monday . The stock traded as high as $29.60 and last traded at $29.4710. Approximately 36,695 shares traded hands during mid-day trading, an increase of 31% from the average daily volume of 27,981 shares. The stock had previously closed at $29.13.
Wall Street Analyst Weigh In
Separately, Zacks Research upgraded Otsuka from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, December 9th. One equities research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock has an average rating of “Strong Buy”.
View Our Latest Stock Analysis on Otsuka
Otsuka Trading Up 1.2%
About Otsuka
Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.
Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.
Recommended Stories
- Five stocks we like better than Otsuka
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Wall Street ‘Sleeper Stock’ Could Become #1 Stock of 2026
- Trump’s Hand-Written Letter Will Shock his Haters
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
